Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$290.92
+0.8%
$301.10
$253.30
$346.85
$156.41B0.592.79 million shs2.61 million shs
Dow Inc. stock logo
DOW
DOW
$30.61
-0.1%
$33.36
$25.06
$60.19
$21.60B1.066.30 million shs11.30 million shs
The Coca-Cola Company stock logo
KO
Coca-Cola
$72.56
+0.3%
$70.86
$60.62
$74.38
$312.27B0.4515.42 million shs21.07 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+1.93%+3.65%-5.99%+2.44%+4.41%
Dow Inc. stock logo
DOW
DOW
+2.41%+5.54%-10.79%-25.30%-46.97%
The Coca-Cola Company stock logo
KO
Coca-Cola
+0.89%-2.10%+2.86%+15.14%+16.65%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amgen Inc. stock logo
AMGN
Amgen
4.0678 of 5 stars
2.22.03.33.93.42.50.6
Dow Inc. stock logo
DOW
DOW
4.7572 of 5 stars
4.13.01.70.03.03.33.8
The Coca-Cola Company stock logo
KO
Coca-Cola
4.0589 of 5 stars
2.53.03.30.83.32.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.43
Hold$310.576.75% Upside
Dow Inc. stock logo
DOW
DOW
2.13
Hold$38.8626.94% Upside
The Coca-Cola Company stock logo
KO
Coca-Cola
3.05
Buy$75.594.17% Upside

Current Analyst Ratings Breakdown

Latest AMGN, KO, and DOW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/30/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$73.00 ➝ $76.00
4/30/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$84.00 ➝ $86.00
4/29/2025
Dow Inc. stock logo
DOW
DOW
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$45.00 ➝ $34.00
4/25/2025
Dow Inc. stock logo
DOW
DOW
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$30.00
4/25/2025
Dow Inc. stock logo
DOW
DOW
Fermium Researc
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
4/24/2025
Dow Inc. stock logo
DOW
DOW
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingCautious ➝ Cautious
4/24/2025
Dow Inc. stock logo
DOW
DOW
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$38.00 ➝ $32.00
4/22/2025
Amgen Inc. stock logo
AMGN
Amgen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight ➝ Neutral$305.00
4/21/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$74.00 ➝ $78.00
4/17/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$78.00 ➝ $84.00
4/15/2025
Dow Inc. stock logo
DOW
DOW
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Underperform$44.00 ➝ $28.00
(Data available from 4/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$33.42B4.68$29.15 per share9.98$10.93 per share26.62
Dow Inc. stock logo
DOW
DOW
$42.63B0.51$4.51 per share6.79$25.36 per share1.21
The Coca-Cola Company stock logo
KO
Coca-Cola
$47.06B6.64$3.26 per share22.29$6.12 per share11.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$4.09B$7.5538.5313.602.6312.24%176.32%11.71%5/1/2025 (Estimated)
Dow Inc. stock logo
DOW
DOW
$1.12B$0.4019.5010.520.972.60%6.52%2.07%N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$10.63B$2.4729.3822.753.7922.59%45.37%12.24%N/A

Latest AMGN, KO, and DOW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Amgen Inc. stock logo
AMGN
Amgen
$4.18N/AN/AN/A$8.05 billionN/A
4/29/2025Q1 2025
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.71$0.73+$0.02$0.77$11.23 billion$11.13 billion
4/24/2025Q1 2025
Dow Inc. stock logo
DOW
DOW
-$0.01$0.02+$0.03-$0.44$10.31 billion$10.43 billion
2/11/2025Q4 2024
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.51$0.55+$0.04$0.51$10.70 billionN/A
2/4/2025Q4 2024
Amgen Inc. stock logo
AMGN
Amgen
$5.04$5.31+$0.27$1.16$8.87 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$9.523.27%+8.53%126.09%14 Years
Dow Inc. stock logo
DOW
DOW
$2.809.15%N/A700.00%N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$2.042.81%+4.91%82.59%64 Years

Latest AMGN, KO, and DOW Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2025
Dow Inc. stock logo
DOW
DOW
quarterly$0.709.9%5/30/20255/30/20256/13/2025
3/4/2025
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.383.05%5/16/20255/16/20256/6/2025
2/20/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
quarterly$0.512.9%3/14/20253/14/20254/1/2025
2/13/2025
Dow Inc. stock logo
DOW
DOW
quarterly$0.707.29%2/28/20252/28/20253/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
9.62
1.26
0.95
Dow Inc. stock logo
DOW
DOW
0.88
1.61
0.98
The Coca-Cola Company stock logo
KO
Coca-Cola
1.61
1.03
0.84

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Dow Inc. stock logo
DOW
DOW
64.00%
The Coca-Cola Company stock logo
KO
Coca-Cola
70.26%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.69%
Dow Inc. stock logo
DOW
DOW
0.50%
The Coca-Cola Company stock logo
KO
Coca-Cola
0.97%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
25,200537.65 million533.50 millionOptionable
Dow Inc. stock logo
DOW
DOW
37,800705.76 million700.31 millionOptionable
The Coca-Cola Company stock logo
KO
Coca-Cola
82,5004.30 billion4.27 billionOptionable

Recent News About These Companies

The Coca-Cola Company stock logo
Coca-Cola (NYSE:KO) Issues Quarterly Earnings Results
The Coca-Cola Company stock logo
Coca-Cola (NYSE:KO) Shares Up 0.7% After Strong Earnings
The Coca-Cola Company stock logo
Coca-Cola (NYSE:KO) Releases FY 2025 Earnings Guidance
Coca-Cola earnings, JOLTS, Consumer Confidence: What to Watch
Coca-Cola HBC beats quarterly revenue growth estimates
Should You Buy Coca-Cola Stock After Q1 Earnings Beat?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amgen stock logo

Amgen NASDAQ:AMGN

$290.92 +2.36 (+0.82%)
As of 04:00 PM Eastern

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

DOW stock logo

DOW NYSE:DOW

$30.61 -0.04 (-0.13%)
As of 03:59 PM Eastern

Dow, Inc. is a materials science company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes and construction chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Coca-Cola stock logo

Coca-Cola NYSE:KO

$72.56 +0.21 (+0.29%)
As of 03:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.